High Tower Advisors, LLC Nephros Inc Transaction History
High Tower Advisors, LLC
- $71.6 Billion
- Q4 2024
A detailed history of High Tower Advisors, LLC transactions in Nephros Inc stock. As of the latest transaction made, High Tower Advisors, LLC holds 55,710 shares of NEPH stock, worth $91,921. This represents 0.0% of its overall portfolio holdings.
Number of Shares
55,710
Previous 57,210
2.62%
Holding current value
$91,921
Previous $97,000
15.46%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding NEPH
# of Institutions
18Shares Held
4.29MCall Options Held
0Put Options Held
0-
Wexford Capital LP Greenwich, CT3.6MShares$5.94 Million0.94% of portfolio
-
Vanguard Group Inc Valley Forge, PA202KShares$333,2900.0% of portfolio
-
Bard Associates Inc Chicago, IL155KShares$256,1970.09% of portfolio
-
Geode Capital Management, LLC Boston, MA84.9KShares$140,0020.0% of portfolio
-
Elkhorn Partners Limited Partnership Omaha, NE41.4KShares$68,3570.04% of portfolio
About NEPHROS INC
- Ticker NEPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 10,318,800
- Market Cap $17M
- Description
- Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water ...